AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV - Changing to HIV.gov in Spring 2017

MENU

Viral Hepatitis

Hepatitis C Kills More Americans than Any Other Infectious Disease

New CDC studies underscore urgency of hepatitis C testing and treatment, especially for baby boomers  Deaths associated with hepatitis C reached an all-time high of 19,659 in 2014, according to preliminary surveillance data released today by the Centers for Disease Control and Prevention (CDC). A second CDC study, published online today in Clinical Infectious Diseases, shows…

FDA Issues Revised Draft Guidance on Developing New Hep C Treatments

FDA has revised a draft guidance, titled Chronic Hepatitis C Virus Infection: Developing Direct-Acting Antiviral Drugs for Treatment. [PDF 665 KB] The purpose of the guidance is to assist sponsors in the clinical development of direct-acting antiviral (DAA) drugs for the treatment of chronic hepatitis C (CHC) from the pre-investigational new drug application (pre-IND) through…

May Is Hepatitis Awareness Month

Each May, many partners across the federal government, including the Department of Health and Human Services (HHS) and its agencies, join with numerous non-federal and community allies to raise awareness of viral hepatitis during Hepatitis Awareness Month. The month-long observance includes national Hepatitis Testing Day on May 19th. These represent important opportunities to promote hepatitis…

Syringe Services Programs: Requesting a Determination of Need in Consultation with CDC – Webinar.

People who inject drugs (PWID) are at risk for Hepatitis B virus (HBV), Hepatitis C virus (HCV), and HIV infection through the sharing of needles and drug-preparation equipment. The risk of getting and transmitting HIV, viral hepatitis, and other blood-borne infections can be substantially reduced by using a sterile needle and syringe for every injection….

Engaging Faith-Based Groups to Address Viral Hepatitis—Archived Webinar Materials Now Available!

Hepatitis B and C affect as many as 2.2 million and 5.3 million people, respectively, from all walks of life and across the United States.  To be successful, our national response to viral hepatitis requires that all parts of society participate, including faith communities.  Recently, the Department of Health and Human Services (HHS) Office of…

Report Concludes Elimination of Hepatitis B & C in U.S. Feasible

Yesterday the National Academies of Sciences, Engineering and Medicine released Eliminating the Public Health Problem of Hepatitis B and C in the United States: Phase One Report , which affirms that it would be possible to eliminate hepatitis in the U.S. with the right resources, commitment, and strategy. Importantly, the report also concluded that in the…

Understanding the Magnitude of the Viral Hepatitis Epidemics in the United States

In March I had the honor of meeting with an inspirational group of advocates, leaders and researchers who had come to Washington to educate lawmakers about viral hepatitis and its impact on our nation. Their braveness and authenticity was moving. They told their personal stories about living with viral hepatitis, the frustrating experiences with healthcare…

Setting a Path Towards HCV Elimination in the Cherokee Nation: Government, Academia, and Pharma Collaboration

An innovative, multi-party collaborative effort, Hepatitis C in Native Oklahoma: Optimizing Care and Setting a Path Towards Elimination of Disease and Disparity, launched recently to respond to high rates of hepatitis C in the Cherokee Nation (CN). The goal of the new initiative is to eliminate HCV and improve the health of American Indians in…